Kyowa Kirin at ASH 2026
Dec 12–15, 2026 New Orleans, LA ~30k attendees Website
Kyowa Kirin brings 2 presentations to ASH 2026 in New Orleans, and exhibits at Booth 1947. Its research centres on antibody-based treatments and transplant preparation. It covers an alternate mogamulizumab dosing plan for cutaneous T-cell lymphoma and a CD117-targeted antibody for stem cell transplant conditioning.
| Organization | ASH 2026 Attendance |
|---|---|
Kyowa Kirin Tokyo, Japan | |
Japanese pharmaceutical company developing antibody-based medicines, including mogamulizumab for cutaneous T-cell lymphoma. | Booth Exhibiting at Booth 1947 Sat, Dec 1211:00am–5:00pmSun, Dec 1310:00am–5:00pmMon, Dec 1410:00am–2:00pm Poster Mon Dec 14 6:00pm–8:00pm |
Find decision makers at Kyowa Kirin
Tell us what you sell and we’ll find the people at Kyowa Kirin most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction